Neurosense Therapeutics Ltd Stock Performance
as on November 4, 2025 at 8:37 pm IST
Day's Low
$1.05$1.09
3.67%
Downside
52 Week's Low
52 Week's High
$0.8$2.626.61%
Downside
138.53%
Upside
Neurosense Therapeutics Ltd share price movements today
- Previous Close
- $1.08
- Open
- $1.05
- Volume
- 19.2K
- Day's Low - High
- $1.05 - $1.09
- 52 Week Low - High
- $0.8 - $2.6
Neurosense Therapeutics Ltd Historical Returns
- 1 Month Return
- -13.6 %
- 3 Month Return
- -14.29 %
- 1 Year Return
- -12.2 %
- 3 Year Return
- -27.52 %
- 5 Year Return
- 0 %
Neurosense Therapeutics Ltd Stock Fundamentals & Key Indicators
Check Neurosense Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$28.0M
EPS (TTM)
-0.4
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-8.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-2478.16%
Neurosense Therapeutics Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurosense Therapeutics Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $28.0M | NA | NA | 0.00% | |
| BUY | $39.7B | 455.58% | -16.34 | -264.83% | |
| BUY | $60.2B | 211.18% | 1425.12 | 1.36% | |
| BUY | $109.1B | 98.06% | 30.31 | 31.86% | |
| BUY | $68.5B | 9.39% | 15.62 | 32.13% |
Stock Returns calculator for Neurosense Therapeutics Ltd Stock including INR - Dollar returns
The Neurosense Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neurosense Therapeutics Ltd investment value today
Current value as on today
₹94,265
Returns
Returns from Neurosense Therapeutics Ltd Stock
Dollar Returns*
₹5,648 (+5.65%)
Analyst Recommendation on Neurosense Therapeutics Ltd Stock
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Neurosense Therapeutics Ltd. Average target price of $11.5
Neurosense Therapeutics Ltd Share Price Target
Get share price movements and forecasts by analysts on Neurosense Therapeutics Ltd.
What analysts predicted
90.52%UPSIDE
Target Price
$11.5
Current Price
$1.09
Analyzed by
8 Analysts
Target
$11.50
Neurosense Therapeutics Ltd target price $11.5, a slight upside of 90.52% compared to current price of $1.09. According to 8 analysts rating.
Neurosense Therapeutics Ltd Stock’s Investor Sentiment and Interest
Search interest for Neurosense Therapeutics Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Neurosense Therapeutics Ltd Quarterly Profit & Loss
All numbers in Millions USD
Neurosense Therapeutics Ltd Annual Profit & Loss
All numbers in Millions USD
Neurosense Therapeutics Ltd Quarterly Cash Flow
All numbers in Millions USD
Neurosense Therapeutics Ltd Annual Cash Flow
All numbers in Millions USD
Insights on Neurosense Therapeutics Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 923.2% return, outperforming this stock by 950.7%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 173.5% return, outperforming this stock by 185.7%
NEGATIVE IMPACTPrice Dip
In the last 1 month, NRSN stock has moved down by -13.6%
About Neurosense Therapeutics Ltd
| Organisation | Neurosense Therapeutics Ltd |
| Headquarters | Building B, Herzliya, Israel, 4672562 |
| CEO | Mr. Alon Ben-Noon |
| E-voting on shares | Click here to vote |
Key Management of Neurosense Therapeutics Ltd
Name | Title |
|---|---|
Ms. Yael Barak | VP of Quality & Compliance |
Ms. Keren Pushett | Head of HR |
Mr. Eidan Loushi | Lead C.R.A. |
Mr. Alon Ben-Noon | Co-Founder, CEO & Director |
Mr. Or Eisenberg | Chief Financial Officer |
Dr. Niva Russek-Blum Ph.D. | Chief Technology Officer |
Dr. Ferenc Tracik M.D. | Chief Medical Officer |
FAQs
What is Neurosense Therapeutics Ltd share price today?
Neurosense Therapeutics Ltd share price today is $1.09 as on . Neurosense Therapeutics Ltd share today touched a day high of $1.09 and a low of $1.05.
What is the 52 week high and 52 week low for Neurosense Therapeutics Ltd share?
Neurosense Therapeutics Ltd share touched a 52 week high of $2.6 on and a 52 week low of $0.8 on . Neurosense Therapeutics Ltd stock price today i.e. is trending at $1.09,which is 58.08% down from its 52 week high and 36.25% up from its 52 week low.
What is Neurosense Therapeutics Ltd's market capitalisation today?
Neurosense Therapeutics Ltd market capitalisation is $0.00T as on .
How to invest in Neurosense Therapeutics Ltd Stock (NRSN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurosense Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurosense Therapeutics Ltd Shares that will get you 1.3761 shares as per Neurosense Therapeutics Ltd share price of $1.09 per share as on November 4, 2025 at 8:37 pm IST.
What is the minimum amount required to buy Neurosense Therapeutics Ltd Stock (NRSN) from India?
Indian investors can start investing in Neurosense Therapeutics Ltd (NRSN) shares with as little as ₹88.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.70 in Neurosense Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurosense Therapeutics Ltd share’s latest price of $1.09 as on November 4, 2025 at 8:37 pm IST, you will get 9.1743 shares of Neurosense Therapeutics Ltd. Learn more about
fractional shares .